Rendocan is now

cannovex web 3

Developing Cannabis-Based MedicineS

Our Mission

Cannovex is a Belgian-based biotechnology company developing first-in-class cannabis-based medicines.

Starting from a unique and proprietary collection of diversified and rare cannabis genetics, we breed and register highly specific medicinal plants. We go beyond the world’s highest cultivation standards to ensure an ultra-stabilized pattern of plant components. These components are carefully selected to target specific diseases.

Our plant materials serve as a leading-edge API-platform which we develop further into patented prescription medications for many different indications and in diverse pharmaceutical forms and dosages.

In collaboration with EU University Hospitals we bring our products to EMA regulated clinical trials for various diseases, leading to proof-of-concepts (PoC).

These Cannovex PoC are the basis for partnerships with pharmaceutical companies to run end-stage clinical trials and to commercialize our products on a global scale.

Our Company

OUR TEAM

Our core team has multi-disciplinary experience in pharmaceuticals, finance, business, science and a deep understanding the cannabis plant, genetics, cultivation and extraction of active components...

WHAT WE DO

Through cannabis biotechnology and partnering, we create valuable cannabis-based medicines for patients. Learn more about our business, cannabis biotechnology and partnering opportunities...

LATEST NEWS

Read up on the latest news on Cannovex and cannabis biotechnology. Media articles, press releases and company updates. Be the first to know and keep up-to-date with our company and the industry...

Highlights

BELGIUM

Location
Agropolis Kinrooi 100%
Academic Partnerships
Hasselt University 100%
Regulatory Framework
In parliamentary approval process 90%
R&D LICENSE APPLICATION
Draft 25%
Licensing Process
Pending... 0%

THE NETHERLANDS

Location
Brightlands Campus Greenport Venlo 100%
Academic Partnerships
Maastricht University 100%
Regulatory Framework
Office for Medicinal Cannabis (est. 2003) 100%
R&D License Application
Filed 100%
Licensing Process
In admissibility 30%

Partners

CANNOVEX BVBA

Address:

“Bioville”
Agoralaan Abis
3590 Diepenbeek
Belgium

CANNOVEX BV

Address:

“Innovatoren”
Sint-Jansweg 15
5928 RC Venlo
The Netherlands

Close Menu